High demand of popular obesity drug Saxenda; may be going to "wrong" patients

Netherlands Times

26 November 2022 - Since April of this year there has been a high demand for the obesity drug Saxenda, but the weight-loss pill may have been prescribed to the wrong patients. 

The Dutch healthcare institute, Zorginstituut Nederland (ZIN), was already warned about the possibility before the introduction.

Read Netherland Times article

Michael Wonder

Posted by:

Michael Wonder